Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 33Carcinoma, Non-Small-Cell Lung 19Squamous Cell Carcinoma of Head and Neck 18Esophageal Neoplasms 17Nasopharyngeal Carcinoma 11Head and Neck Neoplasms 11Uterine Cervical Neoplasms 10Pancreatic Neoplasms 9Oropharyngeal Neoplasms 8Esophageal Squamous Cell Carcinoma 6Carcinoma, Squamous Cell 6Stomach Neoplasms 4Neoplasms 4Mouth Neoplasms 4Glioblastoma 4Colorectal Neoplasms 4Carcinoma 4Adenocarcinoma 4Urinary Bladder Neoplasms 3Pathologic Complete Response 3Hypopharyngeal Neoplasms 3Thymoma 2Resectable Esophageal Cancer 2Neoplasms by Site 2Nasopharyngeal Neoplasms 2NSCLC 2Lymphoma 2Lung Neoplasms 2Locally Advanced Malignant Neoplasm 2Laryngeal Neoplasms 2

Interventions

Capecitabine 20Oxaliplatin 13Irinotecan 8spartalizumab 6tislelizumab 4Radiation 4Immune Checkpoint Inhibitors 4Fluorouracil 4toripalimab 3Neoadjuvant Therapy 3sintilimab 2camrelizumab 2Radiotherapy 2Leucovorin 2Celecoxib 2veliparib 1peposertib 1nimotuzumab 1irinotecan sucrosofate 1XELOX 1Thymalfasin 1Radiotherapy, Intensity-Modulated 1Injections 1HMPL-013 1Folfox protocol 1Diathermy 1Combined Modality Therapy 1Chemoradiotherapy 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Locally Advanced Rectal Cancer × Chemoradiotherapy × Clear all
NCT04423965 2021-03-23

A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC

First Affiliated Hospital of Zhejiang University

Phase 2 Unknown
220 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡